C. Luscombe et al., ALTERATIONS IN INTRAHEPATIC EXPRESSION OF DUCK HEPATITIS-B VIRAL MARKERS WITH GANCICLOVIR CHEMOTHERAPY, Liver, 14(4), 1994, pp. 182-192
Ducks congenitally infected with duck hepatitis B virus (DHBV) were tr
eated with the guanosine analogue, ganciclovir, and the effect on seru
m and intrahepatic expression of DHBV DNA and viral proteins was exami
ned. After 21 days of ganciclovir treatment, a substantial reduction i
n viraemia occurred; in contrast, the level of circulating DHBV surfac
e antigen was unchanged. Ganciclovir therapy also substantially reduce
d the level of DHBV DNA replicative intermediates and the expression o
f viral core and surface antigen in hepatocytes. However, despite the
antiviral treatment some liver cells, including the bile duct epitheli
al cells and putative oval cells, maintained their intense staining fo
r the viral proteins. Furthermore, DHBV-infected cells in extrahepatic
sites such as the pancreas, kidney and spleen were also unaffected by
ganciclovir treatment. These results suggest that monotherapy with nu
cleoside analogues is unlikely to eliminate chronic hepadnaviral infec
tion, and antiviral programs should be designed to target all cell pop
ulations infected by the virus.